Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreren
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. Verenigd Koninkrijk
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. Onderneming
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Rapport
Vertraagde tijd London Stock Exchange  -  17:35:10 06-02-2023
10580.00 GBX   +0.02%
16:28Beursagenda: buitenlandse fondsen
AM
08:46Tibet Rhodiola Pharma Unit wordt erkend verkoper van hartmedicijn
MT
06:53Beursagenda: buitenlandse fondsen
AM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
Vakgebied
Logo AstraZeneca PLC
AstraZeneca PLC is een van de grootste farmaceutische groepen ter wereld. De netto-omzet is als volgt naar inkomstenbron uitgesplitst:
- productverkoop (97,7%). De netto-omzet wordt per behandelingsgebied uitgesplitst in oncologie (35,7%), cardiovasculaire, nier- en stofwisselingsziekten (21,9%), ademhalings- en auto-immuunziekten (16,5%), en overige (25,9%; ontstekingsziekten, neurologische ziekten, gastro-intestinale en infectieziekten);
- samenwerkingsinkomsten (2.3%).
De netto-omzet is geografisch als volgt verdeeld: Verenigd Koninkrijk (8,7%), continentaal Europa (20,9%), Amerika (37,5%) en Afrika/AziŽ/AustraliŽ (32,9%).

Aantal werknemers : 83 100 mensen.
Verkoop per activiteit
20202021Delta
Oncology8 461.0040.8%9 487.3634.9% +12.13%
Cardiovascular, Renal & Metabolism5 533.5726.7%5 831.4421.4% +5.38%
Respiratory & Immunology4 177.4720.1%4 387.3916.1% +5.03%
COVID-19--2 909.9010.7%-
Rare Disease--2 232.238.2%-
Other Medicines2 017.389.7%1 721.076.3% -14.69%
Collaboration566.932.7%636.952.3% +12.35%
GBP in miljoenen
Verkoop per regio
20202021Delta
United States6 983.2533.6%8 759.5232.2% +25.44%
China4 168.1120.1%4 364.1316% +4.7%
Japan2 001.799.6%2 468.559.1% +23.32%
United Kingdom1 357.666.5%2 359.488.7% +73.79%
Other Asia, Africa and Australasia1 196.245.8%1 729.806.4% +44.6%
Sweden800.093.9%1 688.356.2% +111.02%
Other Rest of Europe1 084.725.2%1 417.145.2% +30.65%
Germany730.693.5%1 080.494% +47.87%
Other Americas593.442.9%874.723.2% +47.4%
France509.222.5%665.312.4% +30.65%
Canada464.772.2%561.332.1% +20.78%
Spain310.371.5%420.271.5% +35.41%
Italy336.101.6%419.541.5% +24.83%
Australia219.911.1%397.731.5% +80.86%
GBP in miljoenen
Managers
Naam Titel Leeftijd Van
Pascal Soriot Chief Executive Officer & Executive Director 62 2012
Aradhana Sarin Chief Financial Officer & Executive Director 48 2021
Menelas Pangalos EVP-Biopharmaceuticals Research & Development 55 2019
Pam Cheng Executive VP-Operations & Information Technology 51 2015
Henry Cremisi Medical Director - -
Regina Danielson SVP, Head-Research & Early Development 58 -
Cindy Hoots Chief Digital & Information Officer - 2020
Katarina Ageborg Chief Compliance Officer & EVP-Sustainability - 2017
Jonathan Thomas Charles Slade Group Treasurer 57 -
Adrian Charles Noel Kemp Secretary 56 2009
Bestuurders
Naam Titel Leeftijd Van
Leif Johansson Non-Executive Chairman 70 2012
Marcus Wallenberg Independent Non-Executive Director 66 1999
Philip Arthur John Broadley Senior Independent Non-Executive Director 61 2021
Nazneen Rahman, Dr. Independent Non-Executive Director - 2017
Sherilyn McCoy Independent Non-Executive Director 63 2017
Deborah DiSanzo Independent Non-Executive Director 62 2017
Tony Mok, Dr. Independent Non-Executive Director 61 2019
Michel Demarť Chairman-Designate 66 2022
Pascal Soriot Chief Executive Officer & Executive Director 62 2012
Euan A. Ashley, Dr. Non-Executive Director - 2020
Aandelen
Stemming AantalPercentage vrij verhandelbaarBedrijfseigen aandelenDrijvend Totaal
Aandeel A 1 1 549 818 422 1 494 650 964 96.4% 0 0.0% 96.4%
Aandeelhouders
NaamAandelen%
BlackRock Investment Management (UK) Ltd. 75 472 151 4,87%
Wellington Management Co. LLP 64 146 178 4,14%
The Vanguard Group, Inc. 53 576 000 3,46%
Investor AB (Investment Company) 51 587 810 3,33%
Capital Research & Management Co. (World Investors) 46 132 337 2,98%
Norges Bank Investment Management 33 949 000 2,19%
BlackRock Fund Advisors 29 534 960 1,91%
BlackRock Advisors (UK) Ltd. 21 258 411 1,37%
GQG Partners LLC 17 788 000 1,15%
BlackRock Advisors LLC 16 145 403 1,04%
Participaties
NaamAandelen%Totale waarde
ASTRAZENECA PHARMA INDIA LIMITED (506820) 18 750 000 75,0% 746 203 688 USD
DIZAL JIANGSU PHARMACEUTICAL CO. LTD. 108 923 023 29,8% 616 870 292 USD
NIOX GROUP PLC (CIR) 71 059 999 16,9% 31 199 603 USD
INNATE PHARMA (IPH) 7 485 500 9,33% 26 283 462 USD
ADC THERAPEUTICS SA (ADCT) 4 011 215 5,22% 15 403 066 USD
ARIDIS PHARMACEUTICALS, INC. (ARDS) 884 956 4,25% 1 044 248 USD
Markten en indexen
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Nasdaq 100, NASDAQ OMX Nordic 120, OMX Nordic 40, OMX Stockholm 30, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200, Stoxx UK 50
Beurscodes
- Bloomberg-code :  AZN:LN
- Reuters Code :  AZN.L
- Datastreamcode :  
Bedrijfsgegevens
AstraZeneca PLC
Cambridge Biomedical Campus 1 Francis Crick Avenue
CB2 0AA Cambridge, Cambridgeshire

Telefoon : +44 (0)20 3749 5000
Fax : +44 (0)20 7604 8151
Internet : https://www.astrazeneca.com/investor-relations.html
Merkenportefeuille
In samenwerking metMijn merken op de beurs
Meer merken vanAstraZeneca PLC
Sector Farmaceutische producten - Andere
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
ASTRAZENECA PLC-5.71%198 277
JOHNSON & JOHNSON-6.82%430 370
ELI LILLY AND COMPANY-7.31%322 186
NOVO NORDISK A/S0.37%309 611
ROCHE HOLDING AG-2.81%269 030
MERCK & CO., INC.-7.22%260 994
ABBVIE INC.-10.15%256 696
PFIZER, INC.-14.01%247 323
NOVARTIS AG-4.85%182 524
BRISTOL-MYERS SQUIBB COMPANY3.47%165 253
AMGEN INC.-6.65%130 818
SANOFI-5.23%115 251
GILEAD SCIENCES, INC.-1.57%105 372
GSK PLC0.14%70 256
BAYER AG17.29%60 427
DAIICHI SANKYO CO., LTD.-4.45%59 466
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.46%49 527
CHUGAI PHARMACEUTICAL CO., LTD0.27%42 431
JIANGSU HENGRUI MEDICINE CO., LTD.11.08%40 367
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD5.60%27 175
ASTELLAS PHARMA INC.-5.83%26 304